Stoke Therapeutics, Inc.STOKNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-7.67%
↑ 97% vs avg
Percentile
P38
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-265.21%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -7.67% | +97.2% |
| 2024 | -271.36% | +78.8% |
| 2023 | -1279.09% | -54.3% |
| 2022 | -828.78% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |
| 2017 | 0.00% | - |